CA2125156A1 - Composition pharmaceutique - Google Patents

Composition pharmaceutique

Info

Publication number
CA2125156A1
CA2125156A1 CA002125156A CA2125156A CA2125156A1 CA 2125156 A1 CA2125156 A1 CA 2125156A1 CA 002125156 A CA002125156 A CA 002125156A CA 2125156 A CA2125156 A CA 2125156A CA 2125156 A1 CA2125156 A1 CA 2125156A1
Authority
CA
Canada
Prior art keywords
pharmaceutically acceptable
compound
acceptable salt
benzopyran
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002125156A
Other languages
English (en)
Inventor
Jonathan Robert Sanders Arch
Nicholas Edward Bowring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919125862A external-priority patent/GB9125862D0/en
Priority claimed from GB929213042A external-priority patent/GB9213042D0/en
Application filed by Individual filed Critical Individual
Publication of CA2125156A1 publication Critical patent/CA2125156A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002125156A 1991-12-05 1992-12-01 Composition pharmaceutique Abandoned CA2125156A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9125862.4 1991-12-05
GB919125862A GB9125862D0 (en) 1991-12-05 1991-12-05 Pharmaceutical composition
GB929213042A GB9213042D0 (en) 1992-06-19 1992-06-19 Pharmaceutical composition
GB9213042.6 1992-06-19

Publications (1)

Publication Number Publication Date
CA2125156A1 true CA2125156A1 (fr) 1993-06-10

Family

ID=26299960

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002125156A Abandoned CA2125156A1 (fr) 1991-12-05 1992-12-01 Composition pharmaceutique

Country Status (15)

Country Link
EP (1) EP0615437A1 (fr)
JP (1) JPH07501538A (fr)
AP (1) AP382A (fr)
AU (1) AU2954292A (fr)
BR (1) BR9206845A (fr)
CA (1) CA2125156A1 (fr)
CZ (1) CZ136394A3 (fr)
HU (1) HUT70745A (fr)
IL (1) IL103952A0 (fr)
MA (1) MA22731A1 (fr)
MX (1) MX9206975A (fr)
RU (1) RU94030464A (fr)
SI (1) SI9200365A (fr)
SK (1) SK65794A3 (fr)
WO (1) WO1993010757A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107706A (en) * 1981-09-25 1983-05-05 Beecham Group Plc Benzopyrans
EP0093535B1 (fr) * 1982-04-28 1986-12-30 Beecham Group Plc Chromènes et chromanes
IL86798A (en) * 1987-06-23 1992-12-01 Sanofi Sa 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them
EP0376524B1 (fr) * 1988-12-13 1995-03-29 Beecham Group Plc Benzopyrane et composés apparentés

Also Published As

Publication number Publication date
AP382A (en) 1995-05-03
WO1993010757A1 (fr) 1993-06-10
MA22731A1 (fr) 1993-07-01
CZ136394A3 (en) 1995-02-15
BR9206845A (pt) 1996-01-02
RU94030464A (ru) 1996-04-27
HU9401681D0 (en) 1994-09-28
MX9206975A (es) 1993-06-01
EP0615437A1 (fr) 1994-09-21
AU2954292A (en) 1993-06-28
SK65794A3 (en) 1995-02-08
SI9200365A (en) 1993-06-30
JPH07501538A (ja) 1995-02-16
HUT70745A (en) 1995-10-30
AP9200454A0 (en) 1993-01-31
IL103952A0 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
EP0739206B1 (fr) Compositions d'apport de medicaments comprenant de la nicotine ou un derive et des microspheres d'amidon, et leur procede de fabrication
US7229607B2 (en) Treatment of respiratory disease
EP1663168B1 (fr) Formulations de nicotine et leurs utilisations
US5169849A (en) Nasal pharmaceutical compositions
JP2000514085A (ja) 医薬シクロスポリンaエーロゾル溶液処方物
EP0365119B1 (fr) Composition pharmaceutique
NL8102054A (nl) Biologisch aktieve mengsels en zouten van heterocyclische verbindingen.
CA2125156A1 (fr) Composition pharmaceutique
EP0266443B1 (fr) Procédé d'inclusion d'un composé solide particulaire dans des formulations du type aérosol de nicotine à inhaler
JP4012994B2 (ja) 抗不安薬
AU3765193A (en) Medicament for the treatment of airways inflammation and airways hyperresponsiveness
JPH0411526B2 (fr)
JPH06500129A (ja) ヌクレオシド誘導体
JPH07138157A (ja) 抗潰瘍剤
EP1104301A1 (fr) Methode de traitement
RU2247559C1 (ru) Противотуберкулёзное средство
JP2501201B2 (ja) 感冒薬
JPH0959158A (ja) ベンズイミダゾール誘導体を含有するぜん息治療剤
JPH0776584A (ja) 内皮細胞障害抑制剤
CN113577059A (zh) 一种用于小儿哮喘的活性药物
JP4248780B2 (ja) 過酸化脂質低下剤組成物
CN1080171A (zh) 药用组合物
JP2001089375A (ja) 感冒用組成物
JPH0141126B2 (fr)
WO1995028921A1 (fr) Agent protecteur du rein

Legal Events

Date Code Title Description
FZDE Discontinued